Bolt Biotherapeutics, Inc.
Pharmaceutical company · Redwood City, California, United States · Nasdaq: BOLT
Bolt Biotherapeutics, Inc. is a pharmaceutical company headquartered in Redwood City, California, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker BOLT. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2021.
Bolt Biotherapeutics at a glance
What does Bolt Biotherapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $15 million sold (2021).
Frequently asked questions about Bolt Biotherapeutics
Where is Bolt Biotherapeutics headquartered?
Bolt Biotherapeutics, Inc. is headquartered in Redwood City, California, United States.
What does Bolt Biotherapeutics do?
Bolt Biotherapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Bolt Biotherapeutics a public company?
Yes. Bolt Biotherapeutics, Inc. trades on Nasdaq under the ticker BOLT.
When was Bolt Biotherapeutics founded?
The earliest incorporation on record for Bolt Biotherapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Soleno Therapeutics IncRedwood City, California, United States
- Xenoport IncRedwood City, California, United States
- MapLight Therapeutics, Inc.Redwood City, California, United States
- Corcept Therapeutics IncRedwood City, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.